Immunization Newsbriefs (c) Copyright
Information Inc., Bethesda, MD. Brought to you by the National Network for
Immunization Information (NNii). Visit NNii's new website at
http://www.immunizationinfo.org.
------------------------------------------------------------
April 15, 2002
U.S. IMMUNIZATION NEWS
"Getting Serious About Stopping STDs"
Business Week Online (www.businessweek.com)
(04/08/02); Shook, David
Pharmaceutical and biotechnology companies are
increasingly developing drugs and vaccines for sexually transmitted diseases
(STDs) other than HIV. The success of AIDS
drugs are helping the search by giving researchers time to work on other
diseases and by providing a blueprint to follow. The U.S. market for a vaccine
for a common STD could be over $1 billion annually. A potentially powerful
vaccine for human papilloma virus helps make Merck the major player in STD
treatments, although GlaxoSmithKline is also working on a vaccine for the
disease.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.